US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Retrophin

24.25

0.0000

Volume:- -

Turnover:- -

Market Cap:1.24B

PE:-14.11

High:24.25

Open:24.25

Low:24.25

Close:24.25

52wk High:24.96

52wk Low:8.98

Shares:51.05M

Float Shares:42.54M

Volume Ratio:- -

T/O Rate:- -

Dividend:- -

Dividend Rate:- -

EPS(TTM):-1.7183

EPS(LYR):-3.4584

ROE:-28.52%

ROA:-6.61%

PB:4.11

PE(LYR):-7.01

Loading ...

Overview Company News Filings

Company Profile

Company Name:

Retrophin

Exchange:

NASDAQ

Establishment Date:

- -

Employees:

- -

Office Location:

- -

Website:

http://www.retrophin.com

Zip Code:

- -

Phone:

- -

Fax:

- -

Introduction:

Retrophin, Inc., a biopharmaceutical company, focuses on the identification, development, and commercialization of therapies for the treatment of rare diseases. Its marketed products include Chenodal, a synthetic oral form of chenodeoxycholic acid for the treatment of radiolucent stones in well-opacifying gallbladders; Cholbam, a cholic acid capsule to treat pediatric and adult patients with bile acid synthesis disorders due to single enzyme defects, as well as for adjunctive treatment of patients with peroxisomal disorders; and Thiola and Thiola EC, a tiopronin tablet for the treatment of cystinuria. The company's product candidates also consist of Sparsentan, which is in Phase III clinical trial for the treatment of focal segmental glomerulosclerosis and immunoglobulin A nephropathy. It has a cooperative research and development agreement with National Institutes of Health's National Center for Advancing Translational Sciences, NGLY1.org, and Alagille Syndrome Alliance for identification of potential small molecule therapeutics for NGLY1 deficiency and Alagille syndrome. Retrophin, Inc. was founded in 2011 and is headquartered in San Diego, California.

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/RTRX/company"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"RTRX","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"RTRX\",,,,,undefined,":{"symbol":"RTRX","market":"US","secType":"STK","nameCN":"Retrophin","latestPrice":24.25,"timestamp":1605733200000,"preClose":24.25,"halted":8,"volume":0,"delay":0,"changeRate":0,"floatShares":42544355,"shares":51051820,"eps":-1.718262,"marketStatus":"Trading","change":0,"latestTime":"05-07 12:19:23 EDT","open":24.25,"high":24.25,"low":24.25,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-1.718262,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1778184000000},"marketStatusCode":2,"symbolChange":{"newSymbol":"TVTX","executeDate":"2020-11-19"},"adr":0,"adrRate":0,"listingDate":1389330000000,"exchange":"NASDAQ","adjPreClose":24.25,"volumeRatio":0},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"RTRX\",,,,,undefined,":{"symbol":"RTRX","floatShares":42544355,"roa":"-6.61%","roe":"-28.52%","lyrEps":-3.458364,"shares":51051820,"dividePrice":0,"high":24.25,"amplitude":0,"preClose":24.25,"low":24.25,"week52Low":8.98,"pbRate":"4.11","week52High":24.96,"institutionHeld":0,"latestPrice":24.25,"eps":-1.718262,"divideRate":0,"volume":0,"delay":0,"ttmEps":-1.718262,"open":24.25},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/RTRX\",params:#limit:5,,,undefined,":[{"market":"US","date":"2020-11-19","symbol":"RTRX","oldSymbol":"RTRX","defaultRemindTime":1605796200000,"newSymbol":"TVTX","exchange":"NASDAQ","type":"symbolChange","dateTimestamp":1605762000000},{"market":"US","date":"2020-11-05","symbol":"RTRX","fiscalQuarterEnding":"2020/09","expectedEps":-0.59,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1604552400000,"reportTimeType":"post","actualEps":-0.44},{"market":"US","date":"2020-07-30","symbol":"RTRX","fiscalQuarterEnding":"2020/06","expectedEps":-0.58,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1596081600000,"reportTimeType":"post","actualEps":-0.58},{"market":"US","date":"2020-05-11","symbol":"RTRX","fiscalQuarterEnding":"2020/03","expectedEps":-0.68,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1589169600000,"reportTimeType":"post","actualEps":0.02},{"date":"2020-02-24","symbol":"RTRX","type":"earning","reportTimeType":"post","market":"US","fiscalQuarterEnding":"2019/12","expectedEps":-0.64,"defaultRemindTime":1582578000000,"name":null,"time":"Post Market","dateTimestamp":1582520400000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"RTRX\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"RTRX\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/RTRX\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"RTRX","date":"2020-11-17","current":-14.113098,"percent":0.553259,"low":-27.091151,"twenty":9.763529,"median":-16.843749,"eighty":-5.980249,"high":154.813685,"avg":-0.647163,"sd":35.009589,"marketCap":1230859380},"quantilePoints":[],"updateTime":1778166781346},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{},"stockCompanyDetail":{"websiteUrl":"http://www.retrophin.com","stockEarnings":[{"period":"1week","weight":0},{"period":"1month","weight":0},{"period":"3month","weight":0},{"period":"6month","weight":0},{"period":"1year","weight":0},{"period":"ytd","weight":0}],"compareEarnings":[{"period":"1week","weight":0.0313},{"period":"1month","weight":0.1137},{"period":"3month","weight":0.083},{"period":"6month","weight":0.0937},{"period":"1year","weight":0.3132},{"period":"ytd","weight":0.0761}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Retrophin, Inc., a biopharmaceutical company, focuses on the identification, development, and commercialization of therapies for the treatment of rare diseases. Its marketed products include Chenodal, a synthetic oral form of chenodeoxycholic acid for the treatment of radiolucent stones in well-opacifying gallbladders; Cholbam, a cholic acid capsule to treat pediatric and adult patients with bile acid synthesis disorders due to single enzyme defects, as well as for adjunctive treatment of patients with peroxisomal disorders; and Thiola and Thiola EC, a tiopronin tablet for the treatment of cystinuria. The company's product candidates also consist of Sparsentan, which is in Phase III clinical trial for the treatment of focal segmental glomerulosclerosis and immunoglobulin A nephropathy. It has a cooperative research and development agreement with National Institutes of Health's National Center for Advancing Translational Sciences, NGLY1.org, and Alagille Syndrome Alliance for identification of potential small molecule therapeutics for NGLY1 deficiency and Alagille syndrome. Retrophin, Inc. was founded in 2011 and is headquartered in San Diego, California.","yearOnYearQuotes":[{"month":1,"riseRate":0.666667,"avgChangeRate":0.006293},{"month":2,"riseRate":0.857143,"avgChangeRate":0.128953},{"month":3,"riseRate":0.428571,"avgChangeRate":0.079726},{"month":4,"riseRate":0.571429,"avgChangeRate":-0.049728},{"month":5,"riseRate":0.714286,"avgChangeRate":0.101287},{"month":6,"riseRate":0.714286,"avgChangeRate":0.06206},{"month":7,"riseRate":0.428571,"avgChangeRate":-0.016331},{"month":8,"riseRate":0.428571,"avgChangeRate":0.002737},{"month":9,"riseRate":0.285714,"avgChangeRate":-0.059314},{"month":10,"riseRate":0.428571,"avgChangeRate":-0.016599},{"month":11,"riseRate":0.714286,"avgChangeRate":0.073468},{"month":12,"riseRate":0.333333,"avgChangeRate":-0.01992}],"exchange":"NASDAQ","name":"Retrophin","nameEN":"Retrophin"}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"RTRX\",market:\"US\",,,undefined,":null}}